Early tumour shrinkage (ETS) and depth of response (DpR) in the treatment of patients with metastatic colorectal cancer (mCRC)Volker Heinemann, Ulrich Mansmann, Clemens Gießen-Jung et al.|European Journal of Cancer|2015Cited by 185
Left-sided primary tumors are associated with favorable prognosis in patients with KRAS codon 12/13 wild-type metastatic colorectal cancer treated with cetuximab plus chemotherapy: an analysis of the AIO KRK-0104 trialJobst C. von Einem, Dominik Paul Modest, Thomas Kirchner et al.|Journal of Cancer Research and Clinical Oncology|2014Cited by 112